Try Ask OE! Our NEW Advanced AI Enabled Search
Dive into the Largest Database of
Musculoskeletal Evidence
Make a selection below to explore our full database of 12 results matching: "Inhibitor"
ACE Reports
(12 Reports)
ACE Reports
Originals
(0 Articles)
Originals
Podcasts
(0 Videos)
Podcasts
Our AI driven High Impact metric predicts an article's future number of citations by considering the content of the article.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Open Advanced Search
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Spine
Efficacy and safety of upadacitinib, a selective JAK-1 inhibitor in treatment of ankylosing spondylitis: a meta-analysis.
BMC Rheumatol. 2025 01-Feb;():. 10.1186/s41927-025-00467-1
Efficacy and safety of upadacitinib, a selective JAK-1 inhibitor in treatment of ankylosing spondylitis: a meta-analysis.
BMC Rheumatol. 2025 01-Feb;():. 10.1186/s41927-025-00467-1
Shoulder & Elbow
The level of ratio between matrix metalloproteinase-1 (MMP-1) and tissue inhibitor matrix metalloproteinase-1 (TIMP-1) after prolotherapy intervention and the functional outcome in patient with frozen shoulder: A randomized controlled trial.
Medicine (Baltimore). 2023 01-Jul;():. 10.1097/MD.0000000000034356
The level of ratio between matrix metalloproteinase-1 (MMP-1) and tissue inhibitor matrix metalloproteinase-1 (TIMP-1) after prolotherapy intervention and the functional outcome in patient with frozen shoulder: A randomized controlled trial.
This report has been verified by one or more authors of the original publication.
Medicine (Baltimore). 2023 01-Jul;():. 10.1097/MD.0000000000034356
Osteoarthritis
Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial
Mayo Clin Proc. 1999 Nov;74(11):1095-105
Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial
Mayo Clin Proc. 1999 Nov;74(11):1095-105
Arthroplasty
A Prospective Randomized Study Comparing Oral Direct Factor Xa Inhibitor with Lowmolecular- weight Heparin for Evaluation of Surgical Wound Complications Following Total Hip Arthroplasty
A Prospective Randomized Study Comparing Oral Direct Factor Xa Inhibitor with Lowmolecular- weight Heparin for Evaluation of Surgical Wound Complications Following Total Hip Arthroplasty
Osteoarthritis
Omeract-oarsi ‘strict responders’ analysis from results of a randomized, double-blind, placebo-controlled phase 1 study of a novel, intra-articular, injectable, wnt inhibitor (sm04690) in the treatment of osteoarthritis of the knee
Omeract-oarsi ‘strict responders’ analysis from results of a randomized, double-blind, placebo-controlled phase 1 study of a novel, intra-articular, injectable, wnt inhibitor (sm04690) in the treatment of osteoarthritis of the knee
Arthroplasty
Safety and efficacy of edoxaban, an oral factor xa inhibitor, for thromboprophylaxis after total hip arthroplasty in Japan and Taiwan
J Arthroplasty. 2014 Dec;29(12):2439-46.
Safety and efficacy of edoxaban, an oral factor xa inhibitor, for thromboprophylaxis after total hip arthroplasty in Japan and Taiwan
J Arthroplasty. 2014 Dec;29(12):2439-46.
Arthroplasty
Safety and Efficacy of Edoxaban, an Oral Factor Xa Inhibitor, Versus Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty: The STARS E-3 Trial
Thromb Res. 2014 Dec;134(6):1198-204
Safety and Efficacy of Edoxaban, an Oral Factor Xa Inhibitor, Versus Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty: The STARS E-3 Trial
This report has been verified by one or more authors of the original publication.
Thromb Res. 2014 Dec;134(6):1198-204
Spine
New treatment of lumbar disc herniation involving 5-hydroxytryptamine2A receptor inhibitor: a randomized controlled trial
J Neurosurg Spine. 2005 Apr;2(4):441-6
New treatment of lumbar disc herniation involving 5-hydroxytryptamine2A receptor inhibitor: a randomized controlled trial
J Neurosurg Spine. 2005 Apr;2(4):441-6
Physical Therapy & Rehab
A randomised trial of electro-acupuncture for arthralgia related to aromatase inhibitor use
Eur J Cancer. 2014 Jan;50(2):267-76. doi: 10.1016/j.ejca.2013.09.022. Epub 2013 Oct 24
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
A randomised trial of electro-acupuncture for arthralgia related to aromatase inhibitor use
This report has been verified by one or more authors of the original publication.
Eur J Cancer. 2014 Jan;50(2):267-76. doi: 10.1016/j.ejca.2013.09.022. Epub 2013 Oct 24
Arthroplasty
Less blood loss under concomitant administration of tranexamic acid and indirect factor Xa inhibitor following total knee arthroplasty: a prospective randomized controlled trial
Knee Surg Sports Traumatol Arthrosc. 2013 Nov;21(11):2611-7
Less blood loss under concomitant administration of tranexamic acid and indirect factor Xa inhibitor following total knee arthroplasty: a prospective randomized controlled trial
Knee Surg Sports Traumatol Arthrosc. 2013 Nov;21(11):2611-7
Arthroplasty
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery
J Arthroplasty. 2009 Jan;24(1):1-9. Epub 2008 Apr 14
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery
J Arthroplasty. 2009 Jan;24(1):1-9. Epub 2008 Apr 14
Osteoarthritis
A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee
Ann Rheum Dis. 2013 Feb;72(2):187-95. doi: 10.1136/annrheumdis-2012-202239. Epub 2012 Nov 10
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee
Ann Rheum Dis. 2013 Feb;72(2):187-95. doi: 10.1136/annrheumdis-2012-202239. Epub 2012 Nov 10